Pharmaceutical investment enterprises need to realize the advantages of low prices

When pharmaceutical investment is subject to various obstacles, we may wish to use the power of the model rather than the strength of the brand to build investment performance. If "Dacron" and "Starshoop" are large brands that rely on branded products to create sales, then Suizhong Pharmaceutical sells amoxicillin, isatis root, multi-enzyme tablets, etc., with an annual sales of 1 billion yuan. On the scale, there is not a well-known brand drug but it is very popular with agents! Why is this? Because they have different modes of operation: "Population Madman" mode, using low cost to create price advantage to open up the third terminal market! China Pharmaceuticals has grown into a synonym for low-cost generic drug marketing; in the same way, adopting this model is also a way to win.

For investment enterprises, in addition to resource sharing in products, companies (especially SMEs) can also share resources. In the current situation of the pharmaceutical investment market, each company has its own channels and regions that cannot penetrate in the short term. Through these blank markets and blank channels, it is possible to develop the advantages of cooperative alliances. This can maximize market potential and increase The sales and brand influence of a company can be regarded as a win-win situation. However, at the same time, it is also necessary to prevent the impact on the original market order caused by factors such as the market and channel goods.

In addition, pharmaceutical investment promotion companies must continue to summarize the business operations of companies in order to enhance the effectiveness of their operations. Through the communication of different classes and different objects, the company will issue the most pertinent evaluation of the business activities, and these will be summed up into a book, signed by the person in charge of the company, issued to the relevant personnel involved in the operation, so that all personnel understand Gains and losses, clearly the right and wrong of future work. Eventually through this scientific and rigorous business practices, the effectiveness of the company's operations was improved again and again.

With the emergence of new models, more and more pharmaceutical investment merchants have flocked to the road of investment. Everyone is trying to “realize” products as soon as possible. Ever since, small and medium-sized enterprises have rushed to the spotlight, large-scale enterprises have become buzzing, investment advertisements have been overwhelming, and various exhibitions have come one after another. Desperate speculation, clamoring, and desperate investment behaviors abound. Delusional investment remarks have been repeatedly promoted, and investment strategies and aids have also been promoted. An endless stream.